Metyrosine + Placebo
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Velo-cardio-facial Syndrome
Conditions
Velo-cardio-facial Syndrome, Psychosis
Trial Timeline
Jun 1, 2010 → Sep 1, 2011
NCT ID
NCT01127503About Metyrosine + Placebo
Metyrosine + Placebo is a phase 2 stage product being developed by Bausch Health for Velo-cardio-facial Syndrome. The current trial status is terminated. This product is registered under clinical trial identifier NCT01127503. Target conditions include Velo-cardio-facial Syndrome, Psychosis.
Hype Score Breakdown
Clinical
12
Activity
0
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01127503 | Phase 2 | Terminated |